Pharmacogenomics Focus DNA STAT specializes in pharmacogenomic testing and personalization of medicine, offering an opportunity to partner with clinics seeking to expand precision medicine capabilities and integrate pharmacogenomic insights into treatment protocols.

Small Team Agility With 11-50 employees, DNA STAT can be a high-value, fast-moving partner for scalable pilot programs, national rollouts, or targeted hospital group collaborations that leverage rapid implementation and personalized support.

Clinical Support Advantage The service emphasizes customized physician and patient support, creating potential upsell avenues for managed services, education programs, and ongoing pharmacogenomic consultation contracts.

Market Positioning Position DNA STAT alongside large lab competitors by highlighting personalized patient care, comprehensive enzyme testing, and to-the-point customer service as differentiators in strategies aimed at hospitals and clinics seeking differentiation in pharmacogenomics offerings.

Growth Opportunities With revenue in the low to mid single digits and a focus on accessibility of pharmacogenetic information, target expansion into physician networks, MTM-like services, and integration partnerships with EMR systems to streamline pharmacogenomic decision support.